Learn more about the pro­found morbidity and mortality impact of acute GHVD, including the increased risk of developing chronic GVHD, underscor­ing the urgent need for effective prophy­laxis and treatment options.

Explore data on the global economic burden of GVHD, particularly aGVHD, to healthcare systems, highlight­ing the need for more effective prophylax­is and treatment options.

Discover data that support the need to improve efficacy and response of first-line treatment strategies to mitigate the risk of acute GVHD progression to higher grades or to steroid refractory disease, which are associated with worsened outcomes.

Acute GVHD has a negative impact on quality of life. Explore the high symptom burden patients experience that is worsened with high-grade and steroid-re­fractory disease, highlighting the need for effective first-line treatment options to pre­vent disease progression.